NDC 0220-7604

Psorinum

Scabies Lesion Lysate (human)

Psorinum is a Oral Pellet in the Human Prescription Drug category. It is labeled and distributed by Laboratoires Boiron. The primary component is Scabies Lesion Lysate (human).

Product ID0220-7604_5fdb33ec-089f-2754-e053-2991aa0a9855
NDC0220-7604
Product TypeHuman Prescription Drug
Proprietary NamePsorinum
Generic NameScabies Lesion Lysate (human)
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date1983-03-03
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameLaboratoires Boiron
Substance NameSCABIES LESION LYSATE (HUMAN)
Active Ingredient Strength7 [hp_X]/1
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0220-7604-41

80 PELLET in 1 TUBE (0220-7604-41)
Marketing Start Date1983-03-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0220-7604-41 [00220760441]

Psorinum PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1983-03-03

Drug Details

Active Ingredients

IngredientStrength
SCABIES LESION LYSATE (HUMAN)7 [hp_X]/1

OpenFDA Data

SPL SET ID:dd752fa0-bf6b-11e7-8233-424c58303031
Manufacturer
UNII

NDC Crossover Matching brand name "Psorinum" or generic name "Scabies Lesion Lysate (human)"

NDCBrand NameGeneric Name
0220-7604PsorinumSCABIES LESION LYSATE (HUMAN)
0220-7622PsorinumSCABIES LESION LYSATE (HUMAN)
0220-7623PsorinumSCABIES LESION LYSATE (HUMAN)
0220-7624PsorinumSCABIES LESION LYSATE (HUMAN)
0220-7625PsorinumSCABIES LESION LYSATE (HUMAN)
0220-7626PsorinumSCABIES LESION LYSATE (HUMAN)
44911-0097PsorinumPsorinum
62106-6903PSORINUMPsorinum
64117-407PSORINUMSCABIES LESION LYSATE (HUMAN)
69152-1204Psorinum 1MPsorinum
69152-1006Psorinum 200CPsorinum

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.